These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22000694)

  • 1. HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007.
    Rahimi-Movaghar A; Amin-Esmaeili M; Haghdoost AA; Sadeghirad B; Mohraz M
    Int J Drug Policy; 2012 Jul; 23(4):271-8. PubMed ID: 22000694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of HIV epidemics among non-injecting drug users in Iran: a systematic review.
    Amin-Esmaeili M; Rahimi-Movaghar A; Haghdoost AA; Mohraz M
    Addiction; 2012 Nov; 107(11):1929-38. PubMed ID: 22551085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV prevalence among people who inject drugs (PWID) and related factors in Iran: a systematic review, meta-analysis and trend analysis.
    Rahimi J; Gholami J; Amin-Esmaeili M; Fotouhi A; Rafiemanesh H; Shadloo B; Rahimi-Movaghar A
    Addiction; 2020 Apr; 115(4):605-622. PubMed ID: 31631425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.
    Zamani S; Radfar R; Nematollahi P; Fadaie R; Meshkati M; Mortazavi S; Sedaghat A; Ono-Kihara M; Kihara M
    Int J Drug Policy; 2010 Nov; 21(6):493-500. PubMed ID: 20483578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition to injection amongst opioid users in Iran: implications for harm reduction.
    Malekinejad M; Vazirian M
    Int J Drug Policy; 2012 Jul; 23(4):333-7. PubMed ID: 21996166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran.
    Zamani S; Kihara M; Gouya MM; Vazirian M; Nassirimanesh B; Ono-Kihara M; Ravari SM; Safaie A; Ichikawa S
    J Acquir Immune Defic Syndr; 2006 Jul; 42(3):342-6. PubMed ID: 16639351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
    Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
    Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of HIV, HCV, and High-Risk Behaviors for Substance Users in Drop in Centers in Southern Iran.
    Salehi A; Naghshvarian M; Marzban M; Bagheri Lankarani K
    J Addict Med; 2015; 9(3):181-7. PubMed ID: 25748560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV prevalence among non-injecting people who use drugs and related factors in Iran: A systematic review and meta-analysis.
    Gholami J; Rostam-Abadi Y; Rahimi Y; Fotouhi A; Amin-Esmaeili M; Rahimi-Movaghar A
    Drug Alcohol Rev; 2022 Mar; 41(3):666-676. PubMed ID: 34783411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injection drug use, HIV and the current response in selected low-income and middle-income countries.
    Bergenstrom AM; Abdul-Quader AS
    AIDS; 2010 Sep; 24 Suppl 3():S20-9. PubMed ID: 20926924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
    Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
    Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
    Chakrapani V; Kamei R; Kipgen H; Kh JK
    Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV risk behavior among injection drug users in Tehran, Iran.
    Razani N; Mohraz M; Kheirandish P; Malekinejad M; Malekafzali H; Mokri A; McFarland W; Rutherford G
    Addiction; 2007 Sep; 102(9):1472-82. PubMed ID: 17645427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India.
    Ganju D; Ramesh S; Saggurti N
    Harm Reduct J; 2016 Jun; 13(1):21. PubMed ID: 27324253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of HIV and HCV infection among drug users in China.
    Bao YP; Liu ZM
    Int J STD AIDS; 2009 Jun; 20(6):399-405. PubMed ID: 19451325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.